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The Nef protein of human immunodeficiency virus and simian immunodeficiency virus is expressed early in infection and plays an important
role in disease progression in vivo. In addition, Nef has been shown to modulate cellular functions. To decipher Nef-mediated changes in gene
expression, we utilized DNA microarray analysis to elucidate changes in gene expression in a Jurkat CD4+ T-cell line stably expressing SIV-Nef
protein under the control of an inducible promoter. Our results showed that genes associated with antigen presentation including members of the
T-cell receptor and major histocompatibility class 1 complex were consistently down-regulated at the transcript level in SIV-Nef-expressing cells.
In addition, Nef induced a transcriptional profile of cell-cycle-related genes that support the survival of Nef-expressing cells. Furthermore, Nef
enhanced the transcription of genes encoding enzymes and factors that catalyze the biosynthesis of membrane glycolipids and phospholipids. In
conclusion, gene expression profiling showed that SIV-Nef induces a transcriptional profile in CD4+ T cells that promotes immune evasion and
cell survival, thus facilitating viral persistence.
© 2006 Elsevier Inc. All rights reserved.Keywords: SIV-Nef; Immune evasion; DNA microarray; Antigen presentation; Viral persistenceIntroduction
Retroviruses, including human and simian immunodefi-
ciency viruses (HIVand SIV), have evolved elaborate strategies
to evade host immune surveillance in order to replicate and
establish a persistent infection. One of the strategies employed
by HIV and SIV is the impairment of antigen presentation by
down-regulation of host MHC molecules. In addition, HIV
infection subverts the apoptotic machinery in both infected and
uninfected cells, thereby facilitating the survival of virally
infected cells. Among the viral accessory proteins, Nef has been
shown to contribute to immune evasion. The nef gene of HIV
and SIV encodes 25- to 27-kDa myristoylated protein that is
expressed early during the virus life cycle and plays a crucial
role in disease progression (Deacon et al., 1995; Kestler et al.,
1991; Kirchhoff et al., 1995). Multiple cellular functions have
been attributed to Nef protein. Down-regulation of CD4
molecules from the cell surface is the most clearly documented⁎ Corresponding author. Fax: +1 530 754 7240.
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of CD4 to an adaptor protein which targets it for endocytosis
and degradation (Aiken et al., 1994; Bandres et al., 1995; Guy et
al., 1987; Lama et al., 1999; Mariani and Skowronski, 1993;
Rhee and Marsh, 1994). The down-regulation of CD4
molecules is thought to facilitate virion release (Ross et al.,
1999). Nef is also known to modulate T-cell activation through
the interaction between Nef and signal transduction proteins
(Baur et al., 1994; Sawai et al., 1994; Skowronski et al., 1993).
The most pathophysiologically significant effect of Nef on
CD4+ T cells expressing Nef and virally infected cells is the
evasion of immune responses. Nef down-regulates major
histocompatibility complex class I (MHC-I) molecules from the
cell surface (Greenberg et al., 1998; Schwartz et al., 1996; Swigut
et al., 2000). This function of Nef involves indirect interaction
with the cytoplasmic tail of MHC-I A and B molecules leading to
endocytosis and confers partial protection from recognition and
lysis by cytotoxic T cells (Collins et al., 1998; Greenberg et al.,
1998; Schwartz et al., 1996). Nef has also been shown to enhance
virus replication and infectivity through a mechanism that
involves enhanced biosynthesis and transportation of cholesterol
375T. Ndolo et al. / Virology 353 (2006) 374–387and ganglioside to lipid rafts (Zheng et al., 2003). Lipid rafts are
microdomains in the plasma membrane enriched in sphingolipids
and cholesterol that are essential for egress from and entry of HIV
into target cells (Zheng et al., 2001, 2003).
Comparison of SIV and HIV-1 Nef has revealed similarities
and differences in function and structure between these proteins
(Piguet and Trono, 1999). Both SIVand HIV-1 Nef show similar
in vitro activities: down-regulation of CD4 and MHC-I cell
surface expression, enhancement of virion infectivity, stimula-
tion of viral replication in primary lymphocytes, modulation of
T-cell signaling pathway and interaction with cellular serine/
threonine and tyrosine kinases. The Nef proteins of both viruses
contain a myristylated N-terminal and show homology, mainly
in the central domain (Renkema and Saksela, 2000; Shugars et
al., 1993). Despite these similarities, some noteworthy differ-
ences exist between SIV and HIV-1 Nef. In contrast to HIV-1
Nef, SIV-Nef contains additional amino acids residues at the
N-terminus that are absent in HIV-1 Nef. Moreover, SIV and
HIV-1 Nef interact with cellular proteins through distinct motifs
and may utilize overlapping but distinct target sites for CD4
down-regulation (Bresnahan et al., 1998; Craig et al., 1998;
Greenberg et al., 1998; Hua and Cullen, 1997; Lock et al., 1999;
Piguet et al., 1998). HIV-1 Nef contains three repeats of the
putative SH3 binding domain (PxP) important for the binding of
Src family tyrosine kinases. In contrast, SIV-Nef contains only
one corresponding PxP motif (Arold et al., 1997; Lee et al.,
1995; Saksela et al., 1995). Thus, SIV-Nef and HIV-1 Nef are
functionally similar but utilize different mechanisms to carry out
similar functions (Bresnahan et al., 1998; Greenway et al., 1999;
Hua and Cullen, 1997; Iafrate et al., 1997; Lang et al., 1997;
Lock et al., 1999; Piguet et al., 1998).
SHIV nef chimeric viruses, constructed by replacing the
SIVmac 239 nef gene with HIV-1 nef in a SIVmac 239 back-
bone, provided a valuable tool for investigating the interchange-
ability of SIVand HIV-1 Nef protein functions (Kirchhoff et al.,
1999; Mandell et al., 1999; Shibata et al., 1991, 1997; Sinclair et
al., 1997). These studies demonstrated that HIV-Nef expression
in macaque cells exerted similar cellular effects and that HIV
Nef and SIV-Nef are functionally interchangeable. Rhesus
macaques experimentally infected with SHIV nef clones
revealed that HIV Nef induces an AIDS-like disease in
macaques. While the functional equivalence between HIV-1
and SIV-Nef has been demonstrated in vitro and in vivo, the
suitability of the SHIV/macaque model for the study of the role
of HIV-1 Nef in viral pathogenicity is yet to be determined.
Previous work investigating the mechanisms by which Nef
exerts its effects on CD4+ T cells has focused on delineating
posttranscriptional interactions between Nef and cellular
signaling and trafficking proteins (Piguet and Trono, 1999).
However, effects of Nef on the transcription of genes involved
in immune evasion and viral persistence have not been fully
investigated. Given the complexity of pathways mediating these
cellular processes and the paucity of information on the
underlying mechanisms of Nef effects on T cells, we elected
to characterize global gene expression profiles in Nef-expres-
sing CD4+ T cells using DNA microarray analysis. The effects
of Nef on the transcription of cellular genes in different celltypes of epithelial, neural and lymphocytes origin were pre-
viously investigated using DNA microarray analysis (Kramer-
Hammerle et al., 2005; Shaheduzzaman et al., 2002; Simmons
et al., 2001; van't Wout et al., 2005). These studies reported that
Nef induced a transcription profile that enhanced cell activation
and increased expression of genes that regulate apoptosis,
biosynthesis and transport of membrane lipids. However, due to
differences in cell type, the timing and the levels of Nef
expressed, relevance of the processes in Nef-expressing cells
during viral infection has been difficult to ascertain. We
developed a Jurkat T-cell line that stably expresses SIV-Nef
protein under the control of an inducible promoter (Ndolo et al.,
2002). Human T-cell lines have been extensively used for the
expression of SIV-Nef by other investigators and it was shown
that SIV-Nef exerted similar effects as HIV-1 Nef expressed in
human cells (Alexander et al., 1999; Baur et al., 1994; Sawai et
al., 1995; Walk et al., 2001; Yoon et al., 2001). Similar Nef
activities have also been reported in primary rhesus macaques
CD4 T cells infected with SHIV nef recombinant viruses
(Kirchhoff et al., 1999; Mandell et al., 1999; Shibata et al.,
1997; Sinclair et al., 1997). We show that Nef mediates the
down-modulation of the transcription of genes belonging to
members of the MHC-I complex that mediate antigen
presentation, thus facilitating immune evasion. Previous studies
focused on endocytotic mechanisms. In addition, SIV-Nef
enhances the transcription of genes encoding enzymes and
factors that catalyze the biosynthesis of membrane lipids,
facilitating the formation of lipid rafts that are pivotal for
enhanced viral infectivity. Our data are in agreement with
recently reported HIV Nef-mediated up-regulation in T cells of
genes encoding enzymes involved in RNA processing, protein
synthesis and cholesterol biosynthesis (Shaheduzzaman et al.,
2002). Overall, our study indicates that SIV-Nef induces a
transcriptional profile in CD4+ T cells that promotes immune
evasion and cell survival, thus facilitating viral persistence.
Results
Ecdysone-inducible expression of SIV-Nef
Previous attempts to stably express Nef in T cells have
been hampered by the fact that long-term expression of Nef is
toxic and results in selection of truncated Nef protein and
eventual loss of expression (Baur et al., 1997; Baur et al.,
1994; Walk et al., 2001). To overcome these limitations, we
used the ecdysone-inducible expression system to achieve
regulated expression of SIV-Nef in Jurkat T cells. A low basal
level of Nef expression was observed in Jurkat T cells
transfected with the pIND-CD8-nef and pVgRxR plasmids but
in the absence of ponasterone A induction. Since leakage
proof expression of recombinant proteins is difficult to
achieve in inducible protein expression systems, we selected
clone B5 which showed a five-fold increase in Nef expression
upon induction but had a minimal basal expression in Nef-
expressing Jurkat T cells in the absences of ponasterone A
induction (Fig. 1). Expression levels of Nef protein at 24 h
post-induction were found to be equivalent to levels of Nef
Fig. 1. Inducible expression of SIV-Nef in Jurkat T cells. (A) Schematic diagram of pIND-CD8-Nef construct. (B) Schematic diagram of pVgRxR regulatory plasmid.
(C) Stable expression of SIV-Nef in Jurkat T-cell line. Jurkat T cells were stably transfected with plasmids pIND-CD8-Nef encoding CD8-Nef chimera and pVgRxR
encoding Drosophila ecdysone hormone receptor subunits RxR and EcR. Clones resistant to both G418 and Zeocin were screened for SIV-Nef expression by
immunoblotting following induction with ponasterone A. Nef-expressing clone B5 which showed a five-fold increase in Nef expression upon induction and minimal
basal expression in comparison to non-ponasterone-A-induced Nef-expressing Jurkat T cells.
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cells in vivo and CEMx174 cells during early stages of
infection (Ndolo et al., 2002; Walk et al., 2001). As expected,
Nef expression was not observed in ponasterone-A-induced
untransfected Jurkat cells and Jurkat cells stably transfected
with control plasmids. We refer to these controls collectively
as ponasterone-A-induced non-Nef-expressing Jurkat control
T cells in all our subsequent results.
Functional categories of cellular genes modulated by SIV-Nef
We utilized DNA microarray analysis to elucidate changes in
gene expression in Jurkat T cells stably expressing SIV-Nef
protein. Labeled cRNA was hybridized to Affymetrix U133A
GeneChips, and changes in the level of transcription of each
gene were determined by statistical analysis of the difference in
mean fluorescence between ponasterone-A-induced-Nef-
expressing and ponasterone-A-induced non-Nef-expressing
Jurkat T cells over three replicate experiments.
In Jurkat cells expressing SIV-Nef, 3542 genes were
differentially expressed of which 2392 genes were up-regulated
whereas 1232 genes were down-regulated in comparison to
ponasterone-A-induced non-Nef-expressing control Jurkat
cells. The DNA microarray data have been deposited as
supplementary data at the Gene Expression Omnibus database
through the NCBI website. These supplementary data are
available at the following link (http://www.ncbi.nlm.nih.gov/
projects/geo/query/acc.cgi?acc=GSE4785). Genes with
increased or decreased expression were statistically analyzed
for the presence of underlying biological themes (by thepercentage of genes and Fisher exact probability score) as
shown in Fig. 2. Genes up-regulated by Nef were predominantly
involved in lipid metabolism, chaperone activity, protein
targeting and various aspects of RNA metabolism, including
mRNA splicing and processing, transcription, translation and
degradation. Significantly down-regulated functional categories
included defense responses, cell cycle, cell adhesion, cytoske-
letal protein binding, gamma-glutamyl transferase and phos-
phoric ester hyrolase activity and glucose metabolism. The
observed gene expression profile modulated by SIV-Nef in
CD4+ T cells in our study was similar to that reported on HIV-1
Nef (Kramer-Hammerle et al., 2005; Shaheduzzaman et al.,
2002; Simmons et al., 2001; van't Wout et al., 2005).
Expression of antigen processing and presentation genes is
repressed by SIV-Nef
Major histocompatibility complex (MHC), class I transcripts
were among the group of down-regulated genes involved in
defense response (Fig. 2). Transcription of genes associated
with antigen presentation, including MHC 1B, IC, IE, IF and
IG, was significantly down-regulated (Fig. 3A), however, genes
associated with antigen presentation via proteasome degrada-
tion were up-regulated in Nef-expressing cells. In addition,
expression of both 26S and 20S proteasome subunits, ubiquitin/
E2 complex molecules and activators of the proteasome
complex was increased, suggesting that degradation of intact
proteins and peptides may be up-regulated in Nef-expressing
cells (Fig 3B). Previous studies have reported Nef-mediated
down-regulation of HLA-A and B allotypes from the cell
Fig. 2. Hierarchical clustering of genes modulated by SIV-Nef. Hierarchical
clustering was used to identify genes differentially modulated by SIV-Nef.
Twenty broad functional clusters were identified. Genes involved in RNA
metabolism, RNA processing, translation initiation, membrane lipid metabolism
and transcription were up-regulated. Genes involved in antigen presentation,
mitotic cell cycle, defense response, MHC class I receptor activity and tumor
necrosis factor receptor binding were down-regulated. The scale at the bottom
indicated the magnitude of up- or down-regulation (fold change in expression).
Red bars represent up-regulated while green bars represent down-regulated
genes. Black bars represent genes not differentially modulated by SIV-Nef.
Genes were selected based on a ≥1.5-fold change and a p value of ≤0.05.
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lysis (Collins et al., 1998; Schwartz et al., 1996; Swigut et al.,
2000). Our results demonstrated that suppression of MHC genes
at the transcriptional level is also likely to be a key molecular
mechanism for Nef-induced immune evasion.
In addition to MHC class I, we found substantial down-
regulation of the T-cell receptor alpha (−1.7-fold) and gamma
chains (−1.9-fold), SCAP1 (−2.1) and CD69 (−4.6-fold),
suggesting a general suppression of transcription of antigen
presentation molecules (Fig. 3). CD69 is a type II integral mem-
brane protein that also plays a role in modulation of inflamma-tory responses and apoptosis (Foerster et al., 2002; Lopez-
Cabrera et al., 1993, 1995; Santis et al., 1995;Walsh et al., 1996).
Nef-mediated down-regulation of CD69 may suggest a protec-
tive role for Nef against Fas-mediated apoptosis of infected cells
in addition to evasion from cell-mediated immune responses.
SCAP1 encodes an src kinase-associated adaptor phosphopro-
tein preferentially expressed in T cells (Wang et al., 2003).
SCAP1 has been shown to regulate integrin-mediated adhesion
and conjugate formation between T cells and antigen-presenting
cells and positively regulates TCR-mediated gene transcription
(Wu et al., 2002). In the context of known functions of SCAP1,
Nef-mediated down-regulation of SCAP1 may be interpreted to
play a role in the repression of TCR receptor expression, thus
providing additional mechanisms to facilitate immune evasion.
Another category of genes within the immune responses
cluster up-regulated in SIV-Nef-expressing Jurkat T cells in-
cluded CD59 (+2.0-fold change; p<1e−07), CD1D (4.3-fold
change; p<1e−07) and G1P2 (+2.4-fold change; p<1e−07).
CD59 is a membrane protein that regulates complement and
inhibits the formation of membrane attack complex pores on the
surface of CD4 T cells (Rollins and Sims, 1990). Nef-mediated
up-regulation of CD59 expression may protect SIV-Nef-
expressing cells from complement-mediated cell lysis. CD1
genes encode a family of glycoproteins that are related to MHC
molecules and are involved in the presentation of non-peptide
antigens to T cells (Porcelli and Modlin, 1999). CD1D genes
belong to group II, CD1d molecules present α-galactosyl-
ceramide to NK T cells (Kawano et al., 1997). Interestingly, it
has been shown that expression of CD1molecules protects target
cells from NK-cell-mediated lysis, suggesting that Nef-induced
up-regulation of CD1D transcripts in CD4+ T cells may also
serve to protect Nef-expressing cells from NK-cell-mediated
killing (Campos-Martin et al., 2004; Chang et al., 1999). G1P2 is
a member of IFN-stimulated genes (ISGs) and encodes a
ubiquitin-like protein that posttranslationally modifies cellular
proteins by forming covalent conjugates in response to IFN and
other markers of viral infection (Haas et al., 1987). Overall, these
data indicate that SIV-Nef mediated down-modulation at the
transcriptional level of factors involved in antigen presentation
and up-regulation of factors that protect cells from CD8 T cells
and NK-mediated cytolysis provides multiple mechanisms for
immune evasion during viral infection.
SIV-Nef mediated modulation of cell cycle regulators promotes
cell survival and viral replication
SIV-Nef-expressing Jurkat T cells also displayed a complex
dysregulation of genes encoding for proteins involved in cell
cycle regulation. Eight of the ten genes modulated by Nef in this
functional cluster were down-regulated including cyclins G1 and
G2, CHFR, CDK6, HK2, HDAC9, CDC25C, CLK3,
CCNB1P1, CDC2L6, CD40LG and other cell-cycle-related
genes (Fig. 4). The protein encoded by CDK6 is a catalytic
subunit of the protein kinase complex that is important for cell
cycle G1 phase progression and G1/S transition (Meyerson and
Harlow, 1994). CDC25C encodes a cell cycle regulatory protein
belonging to Cdc25 tyrosine phosphatase family (Sadhu et al.,
Fig. 3. Antigen-presentation-associated genes modulated by SIV-Nef. (A) SIV-Nef-expressing Jurkat T cells showed between −5.0 and −1.5-fold down-regulation in
the transcript levels of MHC class I, TCR genes involved in antigen presentation and recognition. (B) Expression of proteasome degradation-related genes, 26S and
20S proteasome subunits and ubiquitin/E2 complex molecules is enhanced in SIV-Nef-expressing Jurkat T cells.
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Fig. 4. Cell-cycle-related gene modulated by SIV-Nef expression. Genes involved in the regulation of the cell cycle such as cyclins and cyclin-dependent kinases were
significantly down-regulated in SIV-Nef-expressing Jurkat T cells. Magnitude of down-regulation in fold change expression is indicated on the x axis.
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bound CDC2 and triggers entry into mitosis (Strausfeld et al.,
1991). CCNB1IP1 encodes for a member of the E3 ubiquitin
ligase family of proteins and modulates cell cycle progression
through G2/M checkpoint (Toby et al., 2003). Down-regulation
of this gene by Nef may delay the entry of cells into mitosis, thus
facilitating the completion of the transcription of viral genes and
viral replication. HDAC9 encodes a histone deacetylase.
Histone acetylation and deacetylation play essential roles in
modifying chromatin structure and regulating gene expression.
HDAC9 has been implicated in modulating the transcriptional
repression of gene expression during cell activation and differen-
tiation, development of inflammation and cell cycle regulation
(Shaffer et al., 2000). Nef-induced down-regulation of HDAC9
may overcome this repression, facilitating T-cell activation
(Esau et al., 2001). CLK3 and CHFR encode for protein kinases
that regulate the transition of cells through G2/M phase cell cycle
checkpoint control (Hanes et al., 1994; Matsusaka and Pines,
2004). The down-regulation of these regulators by Nef may
overcome the G2/M block and exit from the cell cycle, thus
contributing to cell survival and viral replication. CD40LG
encodes for the CD154 (CD40− ligand) which is expressed on
the surface of T cells. CD154 regulates B cell functions by
engaging CD40 on B cell surface (Xu and Song, 2004).
In contrast to the down-regulation of cell-cycle-associated
genes, we found that STAG1 and SKB1 genes were up-
regulated by SIV-Nef (+2.1 and +2.0-fold change respectively).
SKB1 encodes a protein that negatively regulates mitosis
(Gilbreth et al., 1998). Over-expression of SKB1 has been
shown to restore cell morphology and viability in cells whose
transition from G2 to M phase of the cell division cycle has been
blocked, thus inhibiting the exit of cell from G2 phase
(Okayama et al., 1996). STAG1 encodes a subunit of the
cohesin complex, which is required for sister chromatids
cohesion during mitosis and meiosis (Anazawa et al., 2004).
Expression of STAG1 is essential for cell viability (Haering et
al., 2002). Down-regulation of STAG1 and SKB1 transcripts by
SIV-Nef may mediate cell cycle transition at G1/S or G2/Mcheck points. Overall, these data suggest that Nef induces a
transcriptional profile of cell-cycle-related genes that supports
survival of Nef-expressing cells by enhancing their transition
through cell cycle checkpoint controls.
Increased expression of gene regulating RNA processing,
protein biosynthesis and degradation in SIV-Nef-expressing
cells
Annotation of genes modulated by Nef showed that fifty four
genes involved in RNA processing, protein biosynthesis and
degradation were up-regulated in SIV-Nef-expressing T cells
(Table 1). Of the fifty four up-regulated genes, six encode
proteins involved in RNA splicing (SFRS3, SFRS6, SFRS10,
SFPQ, POP1, TSEN2), four encode translation factors (EIF5,
ETF1, EIF1AX, EIF1AY), three encode mitochondrial riboso-
mal proteins (MRPL1, MRPL14, MRPL19), four encode for
protease (IMMP1L, ZMPSTE24, ADAM10, DF, TFRC) and
thirteen encode for transcription factors or protein that interact
with RNA polymerase. HIV-1 Nef has been reported to up-
regulate genes involved in RNA metabolism such as Topoi-
somerase 1, RNA pol II subunits, ElonginA, IPP isomerase,
Crystalin zeta and protein tyrosine kinase 9 in HeLa cells
(Shaheduzzaman et al., 2002). Up-regulation of these factors
may facilitate the production of viral messages required at later
stages of the viral life cycle. HIV-Tat has also been shown to up-
regulate genes associated with translational machinery (de la
Fuente et al., 2002).
Nef increases expression of genes regulating membrane lipid
biosynthesis genes
To determine the biological significance and pathophysiolo-
gical relevance of SIV-Nef modulation of genes involved in
membrane lipid metabolism, we analyzed the specific functions
of the genes in this cluster. The majority of the membrane lipid-
metabolism-related genes with increased expression encoded
enzymes that catalyze various steps of the membrane lipid
Table 1
RNA processing and transcription regulation related genes modulated by SIV-Nef expression
Gene/Transcript Abbreviation Accession # Fold increase
1 AU RNA binding protein/enoyl-Coenzyme A hydratase AUH X79888 1.5
2 Basic leucine zipper and W2 domains 1 BZW1 D13630 1.7
3 Cleavage and polyadenylation specific factor 6, 68 kDa CPSF6 X67336 1.8
4 Cleavage stimulation factor, 3′ pre-RNA, subunit 2, 64 kDa CSTF2 NM 001325 1.8
5 Cleavage stimulation factor, 3′ pre-RNA, subunit 2, 77 kDa CSTF3 NM 001326 1.8
6 Crn crooked neck-like 1 (Drosophila) CRNKL1 AF255443 1.6
7 CUG triplet repeat RNA binding factor 2 CUGBP2 U69546 1.7
8 DEAD (Asp–Glu–Ala–As) box polypeptide 19-like DDX19B AJ237946 1.8
9 DEAD (Asp–Glu–Ala–As) box polypeptide 1 DDX1 NM 004939 1.6
10 DEAD (Asp–Glu–Ala–As) box polypeptide 46 DDX46 NM 014829 1.5
11 DEAH (Asp–Glu–Ala–His) box polypeptide 33 DDX33 NM 020162 1.8
12 Dicer 1, Dcr-1 homolog (Drosophila) DICER1 AB028449 1.6
13 Elongation factor RNA polymerase II-like 3 ELL3 NM 025165 1.6
14 Elongation factor RNA polymerase II, 2 ELL NM 006532 2.1
15 Eukaryotic translation initiation factor 1A EIF1A NM 003758 2.5
16 Eukaryotic translation initiation factor 1A, Y-linked EIF1AY NM 004681 2.2
17 Eukaryotic translation initiation factor 2B, subunit 1 alpha, 26 kDa EIF2B1 NM 001414 1.5
18 Eukaryotic translation initiation factor 3, subunit 1 alpha, 35 kDa EIF3S1 NM 003758 1.8
19 Eukaryotic translation initiation factor 3, subunit 9 alpha, 116 kDa EIF3S9 U62583 1.6
20 Eukaryotic translation initiation factor 5 EIF5 NM 001969 4.7
21 Eukaryotic translation termination factor 1 ETF1 NM 004730 2.3
22 Fatty acid binding protein (psoriasis-associated) FABP5 M94856 1.7
23 FUS interacting protein (serine–arginine rich) 1 FUS NM 004960 1.8
24 Heterogeneous nuclear ribonucleoprotein A/B HNRPAB NM 004499 1.8
25 Heterogeneous nuclear ribonucleoprotein A1 HNRPA1 NM 031157 1.9
26 Heterogeneous nuclear ribonucleoprotein C (C1/C2) HNRPC NM 004500 1.5
27 Huntingtin interacting protein 1 HIP1 AF052288 1.8
28 Hypothetical protein DC50 DC50 NM 031210 1.6
29 LSM5 homolog, U6 small nuclear RNA associated LSM5 AF182291 1.5
30 Mak3 homolog (S. cervisiae) MAK3 NM 025146 1.5
31 Mitochondrial elongation factor, G1 GFM1 NM 024996 1.5
32 NTF2-like export factor 1 NXT1 AF156957 1.5
33 Nuclear protein UKp68 ZC3H14 AF155107 1.9
34 Nuclear RNA export factor 1 NXF1 AF112880 2.1
35 Nucleoporin 160 kDa NUP160 D83781 1.6
36 Poly(A) polymerase alpha PAPOLA X76770 2.5
37 Polymerase (RNA) II (DNA directed) polypeptide I, 14.5 kDa POLR21 NM 006233 1.5
38 RAE1 RNA export 1 homolog (S. pombe) RAE1 U84720 1.5
39 Sideroflexin 4 SFXN4 XM058406 1.6
40 Splicing factor 3a, subunit 1 120 kDa SF3A1 X85237 1.5
41 Splicing factor proline/glutamine-rich SFPQ NM 005066 2.0
42 Splicing factor, arginine/serine-rich 1 SFRS1 NM 006924 1.9
43 Splicing factor, arginine/serine-rich 10 SFRS10 AF057159 1.6
44 Splicing factor, arginine/serine-rich 2 SFRS2 NM 003016 1.7
45 Splicing factor, arginine/serine-rich 3 SFRS3 NM 003017 2.1
46 Splicing factor, arginine/serine-rich 6 SFRS6 NM 006275 2.7
47 Splicing factor, arginine/serine-rich 7, 35 kDa SFRS7 L41887 1.5
48 Splicing factor, arginine/serine-rich, 46 kDa SFRS8 U08377 1.6
49 Synaptotagmin binding, cytoplasmic RNA interacting protein SYNCRIP NM 006372 2.3
50 Transformer-2-alpha HTRA2 NM 013247 1.7
51 Translation initiation factor IF2 EIF2 NM 004090 1.6
52 U2 (RNU2) small nuclear RNA auxiliary factor 2 U2AF2 NM 007279 1.6
53 UPF3 regulator of nonsense transcripts homolog A UPF3A AF318575 1.6
54 Zinc finger protein 265 ZNF265 NM203350 1.5
RNA splicing, translation factors, transcription factors and mitochondrial ribosomal proteins related genes were up-regulated in SIV-Nef-expressing T cells.
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cerol-3-phosphate O-acyltransferase 3, lysophophatidylglycerol
acyltransferase 1, sialyltransferase 10, UDP-Gal:beta GLcNAC
beta 1,4-galactosyltransferase 5 and UDP-glucose ceramide
glucosyltransferase), kinases (ethanolamine kinase), phospha-
tases (sphingosine-1-phosphate phosphatase 1), CDP-diacyl-gylcerol synthase and activating proteins (phospholipase A2-
activating protein and neutral sphingomyelinase activation
associated factor) (Fig. 5). Lysophasphatidic acid acyltrans-
ferase catalyzes the acylation of lysophasphatidic acid to phos-
phatidic acid (Aguado and Campbell, 1998). CDP-diacylgyl-
cerol synthase 2 catalyzes the conversion of phosphatidic acid to
Fig. 5. Membrane lipid-metabolism-related genes modulated by SIV-Nef. Genes encoding enzymes and factors that catalyze the biosynthesis of membrane lipids
(glycolipids and phospholipids biosynthesis) were significantly up-regulated in SIV-Nef-expressing Jurkat T cells. Magnitude of up-regulation in fold changes is
indicated on the x axis.
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biosynthesis (Weeks et al., 1997). Ethanolamine kinase
catalyzes the first committed step in phosphatidyethanolamine
biosynthesis via the CDP-ethanolamine pathway. HIV-1 Nef has
recently been shown to enhance the expression of genes
encoding membrane lipid and cholesterol biosynthesis and
uptake in T cell including ACAT2, DHC24 and CY51A1 that
were observed to be up-regulated by SIV-Nef in our study (van't
Wout et al., 2005). Overall, these data suggested that SIV-Nef
mediated up-regulation of genes encoding enzymes and factors
that catalyze the biosynthesis glycolipids and phospholipids, the
major components of cell membranes provide yet other
mechanisms for role of Nef in the viral life cycle.
Verification of differentially expressed genes
We next sought to verify DNA microarray data by assessing
the transcript levels of thirteen genes by utilizing TaqMan real-
time RT-PCR (Table 2). Overall, real-time RT-PCR results were
in concordance with the DNA microarray results.
Since regulation of RNA transcripts may not correspond to
changes in protein levels, we performed immunoblot analysis to
determine whether the genes shown to be modulated by SIV-
Nef at the transcript level were similarly expressed at the protein
level. We examined expression levels of Bcl-2, an anti-apopto-
tic protein, and cell cycle regulators Cyclin D and Cyclin A
which inhibit apoptosis and suppress cell proliferation respec-
tively and modulated by SIV-Nef. Bcl-2 was up-regulated while
Cyclin A and D were down-regulated in SIV-Nef-expressing
Jurkat cells which were in agreement with the microarray data
(Fig. 6).
Discussion
In the present study, we utilized DNA microarray analysis
to examine the effect of SIV-Nef on the transcription of genesin CD4+ T cells. Alterations in cellular gene expression in
Nef-expressing Jurkat CD4+ T cells are likely to be directly
and specifically relevant to the effects of Nef expression in
CD4+ T lymphocytes during viral infection. The rationale for
our approach is as follows: first, Nef expression levels were
found to be similar to those observed in SIV-infected rhesus
macaque CD4+ T cells during early stages of infection and
CEMx174 cells in vitro (Walk et al., 2001). Second, since
Nef is expressed early in the viral life cycle, examining effect
of Nef expression 24 h post-induction of Nef expression
coincides with the timing of in vivo expression of Nef during
early stages of infection. Third, induction of Nef expression
in Jurkat CD4+ T cells led to distinct qualitative and
quantitative changes in gene expression profiles.
The functional homology between SIV and HIV-1 Nef has
been demonstrated in in vitro systems utilizing SHIV nef
chimeric viruses in macaque primary lymphocytes and macaque
cell lines and the expression of SIV-Nef in human cell line
(Alexander et al., 1999; Baur et al., 1994; Sawai et al., 1995;
Walk et al., 2001; Yoon et al., 2001). Experimental infection of
rhesus macaques with SHIV nef recombinant viral clones has
also demonstrated the functional and pathogenic equivalence of
HIV-1 and SIV nef in vivo (Kirchhoff et al., 1999;Mandell et al.,
1999; Shibata et al., 1997; Sinclair et al., 1997). These studies
highlight the biological relevance of utilizing the SIV-Nef/
human T-cell line system and SHIV nef-infected rhesus macaque
model for studying Nef properties and the role of HIV-1 Nef in
HIV pathogenesis.
We focused our analysis on identification of biological
themes and functional gene clusters rather than on individual
genes. Genes with statistically significant alterations in
transcript levels for six overrepresented Gene Ontology
functional categories were identified and subjected to further
analysis. These included antigen presentation, cell cycle, cell
adhesion and RNA processing, protein biosynthesis and
degradation and membrane lipid metabolism. Our results are
Table 2
Comparison between DNA microarray analysis and TaqMan real-time RT-PCR data




1 Cell division cycle 25C CDC25C NM 001790 −2.0 −2.5
2 Interferon, alpha-inducible protein (CloneIFI-15K) G1P2 NM 005101 +2.4 +2.3
3 BCL2-associated transcription factor 1 BCLAF1 AF249273 +2.3 +2.3
4 TCR gamma variable 9 TRGV9 M13231 −2.0 −2.0
5 Death associated transcription factor 1 DATF1 NM 022105 −3.1 −1.3
6 Cyclin-dependent kinase 6 AW192700 −2.0 −3.0
7 BCL2/adenovirus E1B 19 kDa interacting protein 3 BNIP3 NM 004052 −4.9 −4.5
8 Src family associated phosphoprotein 1 SCAP1 NM 003726 −2.1 −2.0
9 Polymerase (RNA) III (DNA directed) polypeptide B POLR3B NM 018082 +2.8 +2.0
10 Zinc metalloproteinase ZMPSTE24 NM 005857 +2.5 +2.5
11 Polymerase (RNA) I polypeptide C, 30 kDa POLR1C NM 004875 +2.6 +2.2
12 Polymerase (RNA) III (DNA directed) polypeptide B POLR3B NM 018082 +2.8 +2.8
13 Src family associated phosphoprotein 1 SCAP1 NM 003726 −2.1 −2.0
TaqMan real-time RT PCR analysis was used to validate Nef-mediated changes in genes expression observed using DNA microarray. Real-time RT-PCR results were
in concordance with the DNA microarray data.
Fig. 6. Immunoblot analysis of Cyclin A and D1 expression in Jurkat and SIV-
Nef-expressing cells. Immunoblot analysis was used to determine whether genes
modulated by SIV-Nef at the transcriptional level were also regulated at the
protein level. The expression of cell cycle regulatory proteins Cyclin D1 and
Cyclin A was down-regulated in SIV-Nef-expressing T cells.
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by biochemical studies to be modulated by Nef including
immune evasion (Le Gall et al., 1998; Schwartz et al., 1996),
cell cycle regulation (Ndolo et al., 2002) and lipid metabolism
(van't Wout et al., 2005; Zheng et al., 2003).
In our study, Nef-mediated down-regulation of a network of
genes encoding members of the antigen presentation machinery
is a new finding. Among these, MHC-1 and TCR gene families
were significantly suppressed. Interestingly, Nef has been
shown to posttranscriptionally down-regulate the cell surface
expression of MHC-I molecules, more specifically, HLA-A and
HLA-B but not HLA-C or HLA-E (Cohen et al., 1999; Le Gall
et al., 1998; Schwartz et al., 1996). Most reports regarding
mechanisms of Nef-mediated immune evasion have been
inconclusive. Majority of these studies suggest that MHC-I is
internalized from the cell surface by endocytosis and relocalized
to the trans-Golgi networks (TGN) through mechanisms that
have yet to be elucidated (Greenberg et al., 1998; Schwartz et
al., 1996). In addition, recent data indicate that the adaptor
protein AP-1 and PACS are required for the Nef-mediated
down-regulation of MHC-I molecules (Piguet et al., 2000;
Roeth et al., 2004; Wan et al., 1998). Thus, down-regulation of
MHC-1 molecules from the cell surface decreases the recogni-
tion and killing of HIV-1-infected cells by virus-specific
cytotoxic T lymphocytes, thus promoting immune evasion
(Collins et al., 1998). Consistent with previously described Nef-
mediated endocytosis of antigen presentations molecules, our
results also demonstrated a similar down-regulated transcription
of key components of the antigen presentation machinery. In
view of these observations, we speculate that Nef mediates
immune evasion at both the transcriptional and posttranslational
levels. Furthermore, the observation of cellular genes already
known to influence immune evasion and antigen recognition
such as HLA-E among the down-regulated genes provides
additional support, suggesting that some of the differentially
expressed genes whose relationships with Nef have not yet been
characterized but may have some relevance to Nef functions.Another category of genes found to be strongly over-
represented in our expression profiling was cell cycle
regulation. Transcription of a broad range of genes encoding
cyclins, cyclin-dependent kinases, cyclin dependent kinase
inhibitor and growth factors was repressed. The role of Nef in
the suppression of cell cycle progression of CD4+ T cells has
previously been reported (Ndolo et al., 2002). Nef has been
shown to slow the progression of cells through G1/S phase
transition by down-regulation of Cyclin D1 and Cyclin A. In
the present study, suppression of cell-cycle-associated genes in
Nef-expressing cells might have occurred through a different
mechanism involving cell cycle progression through G2/M
check point and chromatin structure. Nef-mediated down-
regulation of CD40− ligand gene transcripts is in agreement
with previous studies suggesting that Nef expression sup-
presses CD40− ligand-dependent immune functions including
growth-inhibitory and anti-apoptosis effects through cell cycle
blockage and CD154-NF-κB signaling, thus providing yet
another mechanism for viral persistence (Qiao et al., 2006;
Swingler et al., 2003).Consistent with our data, HIV-Vpr and
Tat have been shown to down-regulate CD25C and CD2L6,
resulting in the suppression of the progression of cells through
383T. Ndolo et al. / Virology 353 (2006) 374–387G2/M phase check point (Cujec et al., 1997; de Noronha et al.,
2001; Elder et al., 2001; Mahalingam et al., 1998; Meyerson
and Harlow, 1994). It has been suggested that Nef-mediated
suppression of cell cycle progression through the G1/S phase
and G2/M phase transition facilitates the completion of the
transcription of viral genes and completion of viral life cycle.
The Nef-mediated down-regulation of these regulators suggests
that SIV-Nef mediated override of the G2/M phase transition
block and inhibition of cell cycle exit, thus facilitating cellular
viability and viral persistence. It is worth noting that, in a
recent report, ecdysone and its derivatives such as muristerone
and ponasterone were shown to induce strong anti-apoptotic
effects on mammalian cell including changes in the expression
of genes encoding cell cycle regulators contrary to previous
reports (Oehme et al., 2006). However, in our study, the
observed differences in apoptosis and cell cycle gene
expression profiles between ponasterone-A-induced non-Nef-
expressing control and ponasterone-A-induced Nef-expressing
cells were Nef-mediated. Thus, Nef may enhance the survival
of infected cells and viral persistence through different
mechanisms. We speculate that the enhanced expression of
genes encoding RNA splicing factors, translation factors,
mitochondrial ribosomal proteins, transcription factors and
other transcription related genes may be explained by the fact
that viral infection induces a transcriptional profile that favors
viral replication and persistence in the midst of intense antiviral
responses. Modulation of these genes may facilitate viral
transcription and replication.
Several studies have utilized DNA microarray analysis to
investigate transcriptional changes induced by HIV-1 and SIV
both in vivo and in vitro (Chun et al., 2003; Geiss et al., 2000;
George et al., 2003, 2005; Motomura et al., 2004; Sankaran et
al., 2005; van't Wout et al., 2003; Wen et al., 2005). These
studies reported increased expression of genes involved in
chaperone activity, protein targeting and various aspects of
RNA metabolism, including mRNA splicing and processing,
transcription, translation and degradation similar to that
observed in our study. Four of the above studies specifically
examined the effect of HIV Nef expression in different cell
types (Kramer-Hammerle et al., 2005; Shaheduzzaman et al.,
2002; Simmons et al., 2001; van't Wout et al., 2005).
Recently, van't Wout et al. reported that Nef enhanced the
expression of enzymes involved in cholesterol biosynthesis
and regulated by the sterol responsive element binding factor-
2 (SREBF-2) including cholesterol enzymes (IDI1, FDPS,
SQLE, LSS, CYP51, HSD17B7 and DHCR24); one choles-
terol regulator (INSIG1); ten sterol enzymes (HMGCS1,
HMGCR, MVK, MVD, FDFT1, SC4MOL, NSDHL, EBP,
SC5DL and DHCR7) (van't Wout et al., 2005). In the same
study, no significant increase in transcript levels was observed
for three other genes involved in cholesterol biosynthesis
(PMVK, SCAP and INSIG2). Consistent with that study, we
found that genes encoding enzymes and factors that catalyze
various steps in membrane phospholipid and glycolipid bio-
synthesis pathways (PLSCR1, DDHD1, ACAT2 and ACSL1)
were also up-regulated while three genes SC4MOL, HADHSC
and ABCG1 were down-regulated, suggesting that SIV-Nefmay broadly enhance membrane lipid biosynthesis and the
formation of lipid rafts as previously reported (Zheng et al.,
2003). Although the modulated genes may be different, the
overall findings with regard to the specific functional cluster,
i.e. enhanced expression of genes encoding membrane lipid
and cholesterol biosynthesis are essentially similar. Any
differences may be attributed to variations in fold change
cut-offs and p values used for the selection of differentially
expressed genes. More recently, Kramer–Hammerle and
colleagues utilized a combination of data and knowledge-
driven analysis to characterize Nef-induced gene expression
patterns in U251MG cells stably expressing HIV-Nef
(Kramer-Hammerle et al., 2005). This approach revealed at
least three significantly overrepresented Gene Ontology
functional categories including lipid metabolism. Thus, our
findings that genes encoding enzymes catalyzing the
biosynthesis of membrane lipid in were up-regulated in
Nef-expressing Jurkat cells are in agreement with the Kramer-
Hammerle et al. study. We speculate that enhanced biosynth-
esis of membrane lipids may explain the previously reported
Nef-mediated enhancement of viral replication and infectivity
(Zheng et al., 2001).
The effect of Nef on the transcription of cellular genes in
different cell types of epithelial, neural and lymphoid origin
was previously investigated using DNA microarray analysis
(Kramer-Hammerle et al., 2005; Shaheduzzaman et al., 2002;
Simmons et al., 2001; van't Wout et al., 2005). These studies
reported that Nef induced a transcription profile that might
have favored viral replication (Shaheduzzaman et al., 2002;
Simmons et al., 2001). In our study, we found a similar
transcriptional profile of differentially regulated genes to that
reported in these two studies. However, there are clear
differences in the results of the current study presumably due
to difference in cell types. Since HeLa cells are not immune
cells, they do not exhibit the full range of gene transcripts
associated with immune functions. Genes involved in T-cell
activation were not significantly modulated in our study. This
may be due to the fact that Jurkat T cells are transformed and
thus constitutively activated in both Nef-expressing and non-
Nef-expressing cells.
In summary, our results demonstrate that Nef expression in
Jurkat CD4+ T cells induces a transcriptional profile that
promotes viral replication and persistence through sustained
immune evasion and survival of T cells. Indeed, HIV-1 has
evolved Nef-mediated mechanisms both at the transcriptional
and posttranscriptional level to subvert the host immune




Plasmid pCMV/CD8-Nef, encoding the extracellular and
transmembrane domains of human CD8 α chain fused to the
SIVmac 239 nef gene, has previously been described (Sawai
et al., 1995). Multiple studies have shown that the CD8-Nef
384 T. Ndolo et al. / Virology 353 (2006) 374–387chimera has effects on T cells similar to that induced by
constructs expressing wild-type Nef (Baur et al., 1994; Wolf
et al., 2001). Inducible SIV-Nef expression plasmid pIND/
CD8-Nef was generated by subcloning the CD8-Nef chimera
into the ecdysone inducible mammalian expression vector
pIND (Invitrogen, Carlsbad, Ca) as previously described
(Ndolo et al., 2002). Briefly, the CD8-Nef fragment from
pCMV/CD8-Nef was excised using HindIII and XbaI and
cloned into the HindIII–XbaI sites of the pIND vector.
Expression is under the control of Drosophila melanogaster
minimal heat shock promoter and the ecdysone and
glucocorticoid response element (E/GRE) hybrid promoter.
Plasmid pVgRxR (Invitrogen) encodes for the RxR and
VgEcR ecdysone receptor subunits and contains a Zeocin
selection marker. Two non-Nef-expressing constructs were
generated and used as controls, namely: (i) circularized empty
pIND vector (without insert); (ii) pIND-CD8-nef plasmid
containing SIV-nef gene in reverse orientation subcloned into
the pIND vector.
Cell culture, transfection and inducible Nef expression
Jurkat E6-1 T cells and CEMx174 cells (NIH AIDS
Research and Reference Reagents Program, Bethesda, MD)
were maintained in RPMI 1640 supplemented with 10% fetal
bovine serum, 2 mM L-glutamine and 100 U/ml penicillin–
streptomycin (GIBCO-BRL, Rockville, MD). Jurkat E6-1 T
cells were transfected with 20 μg of linearized pIND-CD8-Nef
plasmid by electroporation of 5×106 cell in 0.5 ml growth
media without serum at 250 V and 975 μF using a Gene Pulsor
(Bio-Rad, Hercules, CA) and grown overnight. Transfected
cells were plated in 96-well plates in growth media containing
G418 (1000 μg/ml; GIBCO-BRL) for 14 days. The resulting
stable clones were selected by limiting dilution and main-
tained in the growth media containing 250 μg/ml G418. Cells
from stable clones were expanded and transfected by
electroporation with linearized pVgRxR using similar condi-
tions as described for pIND-CD8-Nef transfection. Cells were
grown overnight and plated in 96-well plates followed by dual
selection in the presence of 250 μg/ml G418 and 200 μg/ml
Zeocin for 14 days. Clones dual resistant to G418 and Zeocin
were expanded and tested for the expression of Nef following
induction with ponasterone A, a synthetic analog of ecdysone.
Anti-SIV-Nef clone 17.2 antibody (NIH AIDS Research and
Reference Reagent Program) was used to detect Nef protein
by Western blotting. A ecdysone-inducible Nef-expressing
clone, B5 was selected and maintained in RPMI 1640
supplemented with 10% FCS, 100 U/ml penicillin–strepto-
mycin, 250 μg/ml G418 and 100 μg/ml Zeocin. Optimal
expression of Nef was attained following induction with 10
μM ponasterone A and 24 h post-induction. Two non-Nef-
expressing Jurkat cell lines were generated by stably
transfecting Jurkat cells with pVgRxR regulatory plasmid
and the control plasmids: (i) circularized empty pIND vector
(without insert); (ii) pIND-CD8-nef plasmid containing SIV-
nef gene in reverse orientation subcloned into the pIND
vector.DNA microarray analysis
RNA extraction, labeling of samples, hybridization to HG-
U133A human GeneChips (Affymetrix, Santa Clara, CA,
USA), staining and scanning were performed as described in
the Affymetrix Expression Analysis Technical Manual. Briefly,
total RNA was extracted from: (i) ponasterone-A-induced non-
Nef-expressing Jurkat T cells; (ii) ponasterone-A-induced SIV-
Nef-expressing Jurkat T cells using RNeasy RNA extraction kit
(Qiagen, Valencia, CA, USA) and used as template for cDNA
synthesis. Fluorescence intensity values generated from hybri-
dized U133A GeneChips® were subjected to comparative
analyses using R statistical software (version 2.01) and BRB
Array tools (version 3.3). Changes in the mRNA levels were
considered only when: (i) the change in expression levels was
statistically significant (p<0.05); (ii) the change was equivalent
to 1.5-fold change above or below the baseline transcription
level in non-Nef-expressing control Jurkat T cells. Biological
processes that were statistically overrepresented within each
hierarchical subcluster were identified using EASE version 1.0
analysis software (Li and Wong, 2001).
Pathway analysis
Assignment of genes to functional categories was performed
through annotation of gene lists using the Affymetrix NetAFFX
web interface, the DAVID (http://apps1.niaid.nih.gov/david)
annotation tool, and through literature-based classification by
hand. Statistically overrepresented (Fisher exact probability
score <0.05) biological processes within subclusters were iden-
tified using EASE (http://apps1.niaid.nih.gov/david) and Path-
way Architect (Stratagene/Ioboin) analysis software. Following
elucidation of biologically enriched themes, the microarray data
were then re-mined and analyzed with focus on identifying and
interpreting all statistically valid changes gene expression
associated with the highlighted pathways. In addition, the mi-
croarray data were analyzed with GenMapp software (Gladstone
Institute: UC, San Francisco) that allows insertion of quantitated
transcriptional changes into physiological pathway maps,
further enhancing assessment of gene regulation in the context
of orchestrated physiological function.
Real-time RT-PCR
The primer probe sets for fourteen genes (a minimum of
three genes for each of the following functional categories:
immune responses; cell cycle regulation; apoptosis and RNA/
protein biosynthesis) were obtained commercially from
Applied Biosystems Inc (Foster City, CA). The house keeping
genes GAPDH and 18S ribosome were used as internal
controls. For each gene, a cycle threshold (Ct) value was
obtained at the cycle that produced a detectable fluorescence
signal. The ‘relative’ Ct value of each gene in functional
categories was determined by subtracting the Ct value of
GAPDH or 18S ribosome from the Ct value of each
experimental gene. An average ‘relative’ Ct value for each
gene was calculated from the triplicate repeats of each cell
385T. Ndolo et al. / Virology 353 (2006) 374–387growth condition. The difference between the average Ct values
was used to calculate the fold change for each gene.
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